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The study is to describe a patient with urticarial lesions which was 
successfully treated with mindfulness and nutraceuticals. A 20-year-old 
female patient with an unmarked past medical history presented with 
diffuse pruritic urticarial lesions associated with breathless and severe 
fatigue, lasting for 5 months. The lesions covered all body, except palms 
and plants. Hospitalized for three days, she received dexamethasone, 
promethazine, and subcutaneous adrenalin and discharged with 
fexofenadine, prednisone, and ranitidine. Mindfulness and relaxation 
practice were instructed and some nutraceuticals. After two months, she 
returned asymptomatic, without any new episodes of urticaria or fatigue. 
Most of the chronic urticaria patients are treated with antihistamines and/or 
steroids. This case illustrates an alternative holistic approach, combining 
mindfulness and relaxation practices with nutraceuticals. This alternative 
therapeutical strategy should be explored by back to back comparison to 









Urticarial is a complex allergic disorder characterized 
by pruritic eruption over the skin. It is commonly caused 
by allergies to food, drugs or other environmental agents 
and it may affect 15% to 20% of the population at least 
once in the lifetime [1]. It has been estimated that up to 
25% of patients with acute urticaria progress to chronic 
urticaria. Chronic urticarial is defined by the occurrence 
of frequent, recurrent skin lesions for at least six weeks 
in the absence of any causative physical or environmental 
trigger. In half of the chronic urticarial symptoms resolve 
in about one year. Conversely, 20% experienced urticarial 
attacks for more than 20 years [1].
Regarding chronic urticaria pathophysiology, it is un-
clear yet. It may be related to immunological mediators 
such as IgE, and igG antibodies directed to igE or even 
other factors that may activate masc cell degranulation of 
histamine. Some authors hypothesize that one of the pos-
sible causative factors is psychological distress, including 
anxiety [19]. Chronic conditions may be associated with 
anxiety or depression, and they occur in urticaria. Several 
potential underlying shared mechanisms can be offered 
to explain the joint presentation of chronic urticaria with 
anxiety and depression. One potential mechanism is the 
existence. The immune system abnormalities occurring in 
CSU, anxiety, and depression may indicate a systemic link 
between the three disorders of shared immune-mediated 
mechanisms, as a systemic immune malfunction is preva-
lent in these conditions [20].
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Treatment modalities for urticaria involve the use of 
anti-histaminic, H2 antagonists, and glucocorticoids [2]. 
More than 50% of patients with urticaria do not respond 
to antihistamines doses that have been approved by the 
US Food and Drug Administration [2]. For these patients, 
higher than recommended doses are usually used in the 
clinical practice, and this approach may lead to a higher 
incidence of drug side effects, limiting the use of these 
medications [2]. 
New modalities of treatment of chronic urticaria are 
definitely welcomed. In this regard, the inclusion of be-
havioral practices combined by a non-pharmacological 
nutraceutical approach, with lower risk of side effects, is 
highly desired. 
The present article aims to report a case of a patient 
with recurrent chronic urticarial that was successfully and 
quickly treated with mindful and behavioral therapies 
combined with nutraceutical additives. 
2. Case Report
A 20-year-old female patient with a negative past med-
ical history presented with a 5-month history of diffuse 
pruritic and erythematous skin eruption compatible with 
urticaria, associated with breathless difficulties and se-
vere fatigue. The lesions covered all body, except palms 
and plants. She was hospitalized in May 2018 and re-
ceived dexamethasone, promethazine, and subcutaneous 
adrenalin. One month later the disease relapsed and was 
controlled with antihistamines (fexofenadine 120 mg), 
prednisone, and ranitidine only during acute attacks. In 
August 2018, a new relapse with a more diffuse and se-
vere clinical picture of urticaria, but less pruritic appeared. 
Coming to our clinical facility, the woman denied any 
background diseases, previous use of long term medica-
tions, allergies, asthma, and food intolerance. On physical 
examination she demonstrated urticarial plaques on arms 
and face (Figure 1A), trunk, and legs (Figure 1B), and she 
was very anxious. A Beck anxiety inventory of 21 (normal: 
< 8) was calculated [3]. Laboratory tests showed white 
blood count of 25,900/mm3 (neutrophils 5,160/mm3, lym-
phocytes 1,672/mm3, eosinophils 76/mm3), negative HIV 
1 and 2 and syphilis serologies, total IgG 1264 mg/L (730-
1620 mg/dL), IgM 172 mg/dL (50-300 mg/dL), IgA 217 
mg/dL (40-350 mg/dL), IgE 355 mg/dL (<100 mg/dL), 
CH50- 158 U (60-265 U), 25-OH-vitamin D 20.4 ng/mL 
( > 30 ng/mL), cortisol 13.1 mcg/dL, vitamin B12 402 pg/
mL, C-reactive protein < 0.03 mg/L. Antinuclear antibod-
ies, anti-Ro/SS-A, anti-La/SS-B, anti-RNP, anti-Sm lupus 
anticoagulant, anticardiolipin, rheumatoid factor, IgA and 
IgG antigliadin, anti-endomysium, anti-tissue transglu-
taminase, anti-mitochondrial, anti-myeloperoxidase, an-
ti-proteinase 3, anti-insulin, anti-GAD were all negative. 
Serology for infectious diseases (syphilis, hepatitis B and 
C, cytomegalovirus, Epstein-Barr, rubella, HIV 1 and 2, 
HTLV I and II, and dengue) were all negative. Since she 
was symptomatic with low quality of life, it was offered 
a practice of mindfulness and an intake of the following 
supplements twice a day for 30 days: 5-hydroxytryptamine 
100 mg, vitamin C 500 mg, magnesium 100mg, vitamin 
D3 10,000IU, vitamin A 10,000IU, quercetin 120 mg, and 
L-methionine 500mg. Omega-3 2 g per day, glutamine 5 
g/day for microbiome reinforcement and valerian extract 
1g in the morning and 2 g at night for anxiety, were also 
included. After two months, she returned asymptomatic, 
without any new episodes of urticaria or fatigue. No anti-
histamines, ranitidine, or glucocorticoids were consumed, 
during this period. Beck anxiety inventory returned back 
to normal in 3. Valerian was then reduced to 1 g twice a 
day, and the additives were reduced to 5-hydroxytrypt-
amine 100 mg, vitamin C 500 mg, magnesium 100 mg, 
and vitamin D3 10,000IU once a day, and methyl cobala-
min 200 mcg. Currently, two years after, the patient is as-
ymptomatic, without fatigue, she had one or two episodes 
of mild urticarial per year, still practicing mindfulness and 
relaxation and no need more supplements for urticarial.
   
Figures 1A and 1B. Urticaria lesions over the arm and 
face (1A) and legs (1B) of the patient
3. Discussion
This article reports a female patient who suffered re-
current urticaria and was successfully treated with several 
supplements and mindfulness exercises. 
When a physician deals with chronic urticaria, the 
history of contacts, ingestions, inhalations, prescriptional 
and over the counter drug intake is mandatory. In fact, the 
leading cause of urticarial is idiopathic, comprising 75% 
of the cases. Drugs are responsible for only 9% of the 
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urticarial etiology, and food additives, preservatives, and 
pseudo allergens are the most common offenders [4].
Therapeutic strategies are wide. If the causative agent 
is identified, its elimination is most rewarding and if no 
etiology is identified, most probably, the patient will get 
anti-allergic medications. In the present woman, the an-
tihistamines and steroid were effective only in the acute 
phase during hospitalization. Since the urticaria relapsed 
and the drugs’ side-effects were a concern, an alternative 
therapeutic strategy was searched.
A combination of strategies was employed to rescue 
the young woman from her complains and low quality of 
life. Hence, the patient was supplemented with vitamin 
D due to her deficiency, supported by the literature on 
vitamin D in urticaria. A systematic review of 17 stud-
ies supported vitamin supplementation [5]. Furthermore, 
a randomized, prospective, blinded trial demonstrating 
symptom improvement when a high dose of vitamin D3 
supplementation is added to the conventional treatment [6]. 
Furthermore, this vitamin may improve quality of life, be-
sides the skin symptoms, in 60 chronic urticarial patients 
who received 20,000IU/day of vitamin D2 [7].
Regarding magnesium, a study evaluating magnesium 
kinetics in acute urticarial showed low levels of this min-
eral in urticaria [8].
Stress is a crucial factor related to urticarial pathophys-
iology. The present patient got some supplements intend-
ing to reduce stress, including valerian and 5-hydroxy-
tryptamine [9-11]. And more interesting, 5-hydroxitriptamine 
seems to have a role in reducing the allergic inflamma-
tion[11]. Notably, stress and dysbiosis are vital factors in 
the urticarial pathophysiology [9,12]. Likewise, quercetin, 
vitamin A, and glutamine were added to the patient to im-
prove dysbiosis and reduce stress [13,14]. A study in HIV pa-
tients using supplementation with glutamine for six weeks 
was able to show that this short-term dietary supplemen-
tation attenuated HIV-associated intestinal dysbiosis [14,15]. 
It should be stressed that their effects on skin microbiome 
are unknown. 
Mindfulness and relaxation, are mind-body techniques 
with beneficial results for anxiety therapy. However, no 
study on mindfulness in urticarial was found in the liter-
ature. Briefly, in our patient, we asked her to practice this 
technique deliberately focusing awareness on everyday 
activities and savouring pleasant experiences, to stay in a 
suggested posture with the eyes closed and to observe her 
attitude, feelings and how attention is directed.
Concerning omega-3, an experimental study suggested 
that omega-6 and omega-3 series of polyunsaturated fatty 
acids may be one of the mediators in chronic urticarial [16]. 
Reinforcing omega-3 over omega-6 is known to improve 
tissue injury and wound healing [17].
Ascorbic acid or vitamin C has an anti-histaminic ac-
tion [18]. In this line, it is logical to supplement vitamin C 
in patients suffering from chronic urticaria. 
Future randomized and controlled studies using vitamin 
D, omega-3, magnesium, and other supplements are de-
sired to confirm the efficacy and quick response observed 
in the herein described patient.
Other possible expalantions for the patient improve-
ment may be due to the natural history of the disease, 
changes in exposures, changes in life circumstances, 
residual effects of pharmacological interventions, natu-
ropathic interventions. Indeed, the patient changed her 
life style including mindfulness practice and diet changes 
with gluten-free diet. Regarding natural history of the 
disease, the general consensus is that about one-third to 
one-half of patients with chronic urticaria will have re-
mission of their disease within 1 year. More recent studies 
that have looked at remission rates in children, estimate 
that remission rates are low and are only about 10.3% 
per year [Netchiporouk E, Sasseville D, Moreau L, Habel 
Y, Rahme E, Ben-Shoshan M. Evaluating comorbidities, 
natural history, and predictors of early resolution in a co-
hort of children with chronic urticaria. JAMA Dermatol. 
2017;153(12):1236–42.].
In conclusion, the present successfully treated woman 
brings up an alternative, safe and efficacious treatment of 
chronic urticaria using a holistic approach of nutraceutical 
supplements and behavioral protocol of mindfulness and 
relaxation. 
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